2023 Legislative Session Recap

capitol building

capitol buildingThe Michigan Legislature officially adjourned sine die for the calendar year Nov. 14. The top priority for the association this fall was opposing harmful, one-size fits all nurse staffing ratio legislation (House Bills 4550-4552 and Senate Bills 334-336). The House Health Policy Committee took testimony on the legislation where the MHA and member nursing leaders participated, but the committee did not take the legislation up for a vote and will not do so this calendar year. While much attention was dedicated to opposition to nurse staffing ratio legislation, the final weeks of session included action on a variety of other bills that impact Michigan hospitals and health systems. Below is a summary of where proposed legislation currently stands that the MHA has been monitoring.

Affordable Care Act State Codification – Signed by the Governor

The legislature acted on a group of bills that add protections found in the Affordable Care Act to Michigan law. Governor Whitmer signed House Bills (HBs) 4619-4623 and Senate Bills (SBs) 356-358 into law and they are now Public Acts (PAs) 156-163 of 2023. These new laws memorialize important protections for Michiganders such as no-cost essential services, including preventive, mental health and emergency services. The MHA supported this bill package throughout the legislative process.

Violence Against Healthcare Workers – Awaiting Governor’s Signature

HBs 4520 and 4521, which increase the penalties for assaulting a healthcare worker, are headed to the governor’s desk to be signed into law. These bills are a positive step in ensuring violence against healthcare workers is not tolerated. The MHA continues to work on more opportunities to protect the healthcare workforce from violence in the workplace.

Auto No-Fault Updates – Passed the State Senate

The MHA continues to advocate for targeted updates to the state’s auto no-fault insurance law. SBs 530 and 531 passed the Senate and were referred to the House Insurance and Financial Services Committee. The MHA supports the changes proposed in this legislation, including moving reimbursement rate tiers back to the 2021 levels, smoothing the indigent volume factor timeline and creating an appropriate definition of Medicare rates for the purpose of auto no-fault insurance claim reimbursement.

Telemedicine Access – Passed the State House

HBs 4131, 4213, 4579 and 4580, which provide payment parity for telehealth services and provide limitations on the ability of health plans to dictate site specific visit requirements, were voted out of the House. The MHA supported the bipartisan package, which codifies many provisions in place during the public health emergency (PHE). The legislation makes additional changes to support the provider ability to serve patients and protect in-person visits that are vital to health outcomes. The bills were referred to the Senate Health Policy Committee.

Sharps Containers – Passed the State Senate

The Senate unanimously passed SB 482, which lifts the state’s 90-day disposal requirement for sharps containers. The MHA membership voiced concerns about the 90-day disposal requirement, which mandated sealing and disposing of containers before they reach their ¾ fill mark. The FDA regulated containers are costly and difficult to obtain, as hospitals experienced following a manufacturing facility fire. Disposal of partially full containers contributes to unnecessary and preventable medical waste. The MHA worked directly with the bill sponsor, Sen. Kristen McDonald Rivet (D-Bay City), on this legislation to address concerns about cost, access and environmental impact. The MHA supports this important policy change that will directly benefit the membership.

Behavioral Health Parity – Passed the State Senate
The Senate approved SB 27, which would ensure behavioral health parity laws are meaningfully applied at the state level, with a strong bipartisan vote. The MHA-supported legislation was referred to the House Health Policy Committee. Similarly, the House Health Policy Committee reported out HB 4707, which would specify behavioral health parity, in addition to other services that would be required to be covered. HB 4707 awaits a vote by the full chamber.

Maternal and Infant Health – Passed Committee

HBs 5167-5173, which present several opportunities to support maternal and infant health, were reported out of the House Health Policy Committee. The MHA worked closely with the bill sponsors and committee chair on the legislative language and supports several bills in the package, including:

  • HBs 5167 and 5168, which allow for coverage of blood pressure monitors by commercial insurance and Medicaid for individuals who are pregnant or within the postpartum period.
  • HB 5169, which allows for mental health screenings to take place in postpartum follow up and pediatric settings when clinically appropriate. This bill was paired with HBs 5170 and 5171 that require insurance coverage for those screenings.
  • HB 5172, which sets up an opportunity for the state to publish maternal levels of care verifications and offer incentive payments for participation in verification and safety bundle utilization.

This package of bills awaits a vote by the full House and further legislative action is anticipated in the new year.

Rare Disease Advisory Council – Reported out of Committee

The Senate Health Policy Committee reported out HB 4167, which creates the Rare Disease Advisory Council, after being approved by the full House earlier in the year. The MHA supports this legislation and expects further action on it in 2024.

Breast Milk Donor HIV Testing – Reported out of Committee

The House Health Policy Committee reported out HB 4728, which updates the requirements for testing a breast milk donor for HIV or an HIV antibody. The proposed legislation removes the requirement to test a donor quarterly, while retaining the requirement for initial testing for potential donors. The MHA supports this legislation. HB 4728 is awaiting a vote by the full House.

340B Contract Pharmacy Legislation – Introduced

MHA member covered entities continue to share concerns about manufacturer-imposed limitations on contract pharmacy arrangements. The MHA worked with Rep. Alabas Farhat (D-Dearborn) to introduce legislation prohibiting contract pharmacy arrangement discrimination. HB 5350 was officially introduced on the last day of session for the year and referred to the House Health Policy Committee.

Interstate Nurse Licensure Compact – Introduced
HB 4935, also known as the Michigan Nurse Licensure Compact (NLC), would enter Michigan into the national Nurse Licensure Compact. The NLC allows registered nurses to have one multistate license with the privilege to practice in their home state and other compact states. Permanent relocation to another compact state requires obtaining licensure in the new state, as the nurse’s residency has changed. HB 4935 would declare Michigan a compact participating state, allowing the mutual recognition of nursing licenses among the other member compact states. The bill was referred to the House Health Policy Committee.

Opposition to Repeal of Local Government Labor Regulatory Limitation Act

The Senate did not take a vote on SB 171, sponsored by Sen. Sean McCann (D-Kalamazoo). The bill repeals the local government labor regulatory limitation act, which prohibits localities from regulating employment relationships. Repealing this act would allow for a local unit of government to impose local labor ordinances such as a higher local minimum wage than the state, or potentially institute local staffing and scheduling regulations. The MHA and a coalition of other business and employer groups oppose this legislation over concerns of a patchwork of local regulations that could jeopardize access to healthcare services in Michigan.

Additional MHA Supported Legislation Signed by or Awaiting Signature from Gov. Whitmer

  • SB 219 preserved many PHE flexibilities regarding vaccinations and testing services offered by a pharmacist at a local pharmacy. Michigan continues to see post-PHE declines in vaccination rates. Promoting increased access points for individuals to get vaccinated is a public health benefit and one the MHA supports. Gov. Whitmer signed SB 219 into law in late July 2023.
  • HBs 4495-4496 cleaned up aspects of the Health Michigan Plan Act (HMP), including removal of cost sharing requirements that have proved to be exceedingly burdensome, and the elimination of language requiring the repeal of the HMP if state costs ever exceeded state savings. The HMP has increased access to healthcare throughout the state, providing coverage for over a million Michiganders. The MHA supported this legislation, which the governor signed into law in July 2023.
  • HBs 4616 and 4617 prohibit mental health professionals from providing conversion therapy to a minor. The MHA supported the legislation, which Gov. Whitmer signed into law in August 2023 and are now PAs 117 and 118 of 2023.
  • SB 384 and HBs 4362-4364 make positive changes to state law related to organ donation. SB 384 prohibits insurance discrimination against a living organ donor and HBs 4361-4364 allow for increased opportunities to identify as an organ donor. These changes have the potential to increase organ donation, helping the many individuals in need of transplants. The MHA supported this bill package which, Gov. Whitmer signed into law in November 2023. The bills are now PAs 100-102 and 192 of 2023.
  • SB 227 will update the state’s child caring institution licensing laws to align with emergency intervention language used in the Mental Health Code. Specifically, this legislation is important to any facility interested in becoming licensed as a Pediatric Residential Treatment Facility (PRTF) and alignment between the Mental Health Code and the licensing structure for child caring institutions. SB 227 is headed to the governor’s desk for her signature.
  • SB 133 would create the Overdose Fatality Review Act. The MHA worked closely with the bill sponsor to ensure language in the bill accurately includes and reflects the role hospitals play in their communities. The governor is expected to sign the bill into law soon.
  • SB 410 rescinds limitations on products liability for drugs with FDA approval. The MHA supports SB 410 which Gov. Whitmer is expected to sign.

Information on healthcare bills proposed during the 2023-2024 legislative session can be found through the MHA state legislative bill tracker.

Members with questions on any of the bills should contact Adam Carlson or Elizabeth Kutter at the MHA.

MHA Monday Report Oct. 16, 2023

MHA Monday Report

First Legislative Policy Panel Meeting New Program Year

The MHA Legislative Policy Panel met Oct. 11 to develop recommendations for the MHA Board of Trustees on legislative initiatives impacting Michigan hospitals. The meeting focused on state legislative updates for the new members of …


Auto No-Fault Hearings Continue, Interstate Compacts Advance

The Michigan Senate Finance, Insurance and Consumer Protection Committee continued to hear testimony during the week of Oct. 9 on Senate Bills 530 and 531. Introduced by Sen. Mary Cavanagh (D-Redford Township) and Sen. Sarah …


ANA-MI Opposes Mandated Nurse Staffing Ratio Legislation

The American Nurses Association – Michigan (ANA-Michigan) publicly announced their opposition Oct. 11 to Senate Bill 334 and House Bill 4550, which require state mandated ratios for hospital nurses. The ANA-MI joins the MHA and …


DEA Plans to Extend Telemedicine Rules for Controlled Substances Through 2024

The Drug Enforcement Administration (DEA) announced pandemic-era rules allowing controlled substances to be prescribed via telemedicine will be extended through Dec. 31, 2024. This extension follows significant opposition to the DEA’s plan to curtail these …


MHA Keystone Center 2022-2023 Annual Report Highlights Quality and Safety Priorities

The MHA Keystone Center recently released its 2022-2023 Annual Report, showcasing its dedication to advancing patient and workforce safety alongside member organizations. The report highlights the healthcare safety and quality improvements made through MHA Keystone Center-led …


MHA to Host Virtual DEI Certificate Program

Save the date for a Diversity, Equity and Inclusion in Healthcare certificate program scheduled for Dec. 7 and Dec. 8 from 11 a.m. to 3 p.m. EST. The event, hosted by the MHA and other …


MiCARE Project Discontinued

The Michigan Care Access Referral Exchange (MiCARE), hosted by Bamboo Health’s OpenBeds solution, will be discontinued effective Oct. 31, 2023. The goal of MiCARE was to create a comprehensive network of behavioral health treatment providers, …


MHA Podcast Covers Program Year Priorities: Behavioral Health, Workforce Restoration, Health Equity and More

The MHA released a new episode of the MiCare Champion Cast, which features interviews with healthcare policy experts in Michigan discussing key issues that impact healthcare and the health of communities. The October 2023 episode, …


The Keckley Report

Paul KeckleyAs HLTH 2023 Convenes, Three Themes speak Volumes about Where U.S, Healthcare is Headed

“In Las Vegas this week, 10,000 healthcare entrepreneurs, investors, purchasers and industry onlookers are gathered to celebrate the business of U.S. healthcare. It follows the inaugural Nashville Healthcare Sessions last month that drew a crowd to Music City touting “the premier healthcare conference set in the most relevant, exciting, and welcoming city in the south.“ …

The root causes of the system’s poor performance are understood and considered: they’re daunting. But that does not impede the willingness of private investors to make bets presuming the future of the U.S. healthcare is not a repeat of its past.“

Paul Keckley, Oct. 9, 2023


MHA CEO Brian PetersMHA in the News

The MHA received media coverage the week of Oct. 9 on rural healthcare challenges and legislation proposing state mandated nurse-to-patient staffing ratios. The Detroit Free Press published an article Oct. 12 on the closure of …

DEA Plans to Extend Telemedicine Rules for Controlled Substances Through 2024

The Drug Enforcement Administration (DEA) announced pandemic-era rules allowing controlled substances to be prescribed via telemedicine will be extended through Dec. 31, 2024. This extension follows significant opposition to the DEA’s plan to curtail these regulations at the conclusion of the COVID-19 public health emergency. The DEA originally issued the first temporary rule to extend telehealth prescribing flexibilities through Nov. 11, 2023. With the forthcoming expiration of the first temporary rule and the ongoing work of the DEA and the Department of Health & Human (HHS) to revise the ruleset, the flexibilities are extended through the end of 2024.

The DEA indicated this extension will provides the DEA, in collaboration with HHS, additional time to carefully develop regulations that expand access to telemedicine while safeguarding against misuse of controlled substances. This delay also enables them to facilitate a smooth transition for patients who rely on telemedicine for controlled substance prescriptions while allowing providers adequate time to align with any forthcoming standards.

This extension will continue to permit all patients, not just those with preexisting providers, to receive controlled substance prescriptions without an in-person visit through the end of 2024. The DEA plans to introduce new standards by the fall of 2024.

Members with questions may contact Kelsey Ostergren at the MHA.

DEA Issues Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

After delaying the final rule for ending COVID-19 telehealth prescribing rules, the Drug Enforcement Agency (DEA) has issued a temporary rule to allow the following:

  • The full set of telemedicine flexibilities regarding prescription of controlled medications that were in place during the COVID-19 public health emergency (PHE) will remain in place through 11, 2023.
  • Additionally, any practitioner-patient telemedicine relationships established on or before Nov. 11, 2023 will continue to be permitted the full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE through a one-year grace period until Nov. 11, 2024. In other words, if a patient and a practitioner have established a telemedicine relationship on or before Nov. 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point are permitted until Nov. 11, 2024.

In the meantime, the DEA is continuing to evaluate the rule and anticipates implementation of a final regulation permitting the practice of telemedicine under certain circumstances. The goal of this temporary rule is to ensure a smooth transition for patients and practitioners that have come to rely on the availability of telemedicine for controlled medication prescriptions, as well as allowing adequate time for providers to come into compliance with any new standards or safeguards put into place by the DEA.

Members with questions should contact Renée Smiddy at the MHA.

Changes to Telemedicine Policy Post-COVID-19 Public Health Emergency

The Michigan Department of Health and Human Services (MDHHS) will rescind certain COVID-19 telemedicine flexibilities beginning May 12, 2023, with the conclusion of the federal health public health emergency. Policy MMP 23-10 outlines flexibilities that will remain permanent and which flexibilities will be rescinded. Notable permanent flexibilities include:

  • Reimbursement: The telemedicine reimbursement rate for allowable services will be the same as the in-person reimbursement rate. Providers must report the place of service as they would if they were providing the service in-person.
  • Audio-Only: Audio-only services will be allowed for the procedure codes CPT/HCPCS 99441-99443 and 98955-98968. The MDHHS will create an audio-only database for providers to reference.
  • Prior Authorizations: There are no prior authorization (PA) requirements when providing telemedicine services for fee-for-service beneficiaries or those accessing behavioral health services through prepaid inpatient health plans/community mental health services programs unless the equivalent in-person service requires a PA. The PA requirements for Medicaid health plans (MHP) may vary and providers should refer to individual MHPs for any PA requirements.
  • MSA 20-09 General Telemedicine Policy Changes will be permanent and remain effective with the Facility Rate subsection redacted.
  • MSA 21-24 Asynchronous Telemedicine Services will be permanent and remain effect.

Rescinded telemedicine policies include:

  • MSA 20-13 COVID-19 Response: Telemedicine Policy Expansion.
  • MSA 20-15 COVID-19 Response: Behavioral Health Telepractice; Telephone (Audio Only) Services.
  • MSA 20-34 COVID-19 Response: Telemedicine Reimbursement for Federally Qualified Health Centers.
  • MSA 20-21 COVID-19 Response: Limited Oral Evaluation via Telemedicine.

Members with questions may contact Renée Smiddy at the MHA.

Legislature Returns to Continue Healthcare-related Work

The Legislature returned the week of Sept.19 to continue work on several pieces of legislation that the MHA is currently monitoring. Committees met in both the House and Senate, taking up legislation that included several new bills supported by the MHA in the areas of behavioral health, rural emergency hospitals, speech-language pathologist licensure and telemedicine.

In the House Health Policy Committee, initial testimony was taken on new legislation to make changes to the preadmission screening process for behavioral health patients. House Bill (HB 6355), introduced by Rep. Graham Filler (R-St. Johns) and supported by the MHA, would memorialize the requirement for preadmission screening units operated by the Community Mental Health (CMH) services program to provide a mental health assessment within three hours of being notified by a hospital of the patient’s need. If a preadmission screening unit is unable to perform the assessment within the three-hour time frame, HB 6355 would also allow for a clinically qualified individual at a hospital who is available to perform the required assessment.

Kathy Dollard, Psychologist and Director of behavioral health for MyMichigan Health, joined the committee to testify in support of HB 6355.

Kathy Dollard, psychologist and director of behavioral health for MyMichigan Health, joined the committee to testify in support of HB 6355. “Strengthening our behavioral health system includes strengthening our behavioral health workforce and that can start with creative solutions like providing clinically qualified hospital personnel the ability to conduct pre-admission screenings,” said Dollard. No votes were held on HB 6355 at this initial hearing.

MHA staff also provided testimony during committee on HB 6380. Introduced by Rep. Andrew Fink (R-Hillsdale), HB 6380 would make the necessary changes to state law to allow for Michigan hospitals to pursue a new federal designation of “Rural Emergency Hospital” (REH) status. A REH designation comes with significant requirements such as limiting total beds to 50, maintaining an average length of stay of 24 hours or less and a required transfer agreement with a level I or II trauma center. Hospitals that choose to convert to a REH will receive enhanced federal reimbursement to provide critical emergency and outpatient services, especially in geographic areas.

Lauren LaPine and Elizabeth Kutter of the MHA testified in support of HB 6380.

Lauren LaPine, director of small and rural hospital programs, MHA, and Elizabeth Kutter, senior director of advocacy, MHA, testified in support of the legislation. “HB 6380 provides rural hospitals in our state with the ability to continue providing care in our most rural communities,” said LaPine. No votes were taken on HB 6380.

Initial testimony on two bills that were previously reviewed by MHA’s Legislative Policy Panel also occurred during committee. Senate Bill (SB) 811, introduced by Sen. Curt VanderWall (R-Ludington), would extend the length of time for an individual to complete a temporary Speech-Language Pathologist license and extend the length of time those temporary licenses are valid. The MHA is supportive of SB 811, which did not see any votes this week.

House committee members also took initial testimony on SB 450, which would ensure that visitors of cognitively impaired patients are permitted in healthcare facilities. Introduced by Sen. Jim Stamas (R-Midland), the bill would prohibit the director of the Michigan Department of Health and Human Services (MDHHS) or a local health officer from issuing an order that prohibits a patient representative from visiting a cognitively impaired individual in a healthcare facility. As written, the legislation does not prevent a healthcare facility from implementing reasonable safety measures for visitors and will still allow for facilities to limit the number of representatives per patient. The MHA is neutral on the bill and will continue to monitor any action taken.

The Senate Health and Human Services Committee took initial testimony on SB 1135, which was introduced by Sen. Mike MacDonald (R-Macomb Township). SB 1135 would specify that previous expansions to Medicaid telemedicine coverage also apply to the Healthy Michigan Program and Michigan’s medical assistance program. Most notably, the legislation would require continued coverage for audio-only telemedicine services. The MHA is supportive of SB 1135, which would continue virtual care policies that have proved to be effective and safe during the COVID-19 pandemic.

In the Senate’s Regulatory Reform Committee, testimony was taken on another MHA-supported bill to regulate the sale of kratom in Michigan. Kratom is a substance of concern with opiate-like effects that has no approved medical use in the United States. HB 5477, introduced by Rep. Lori Stone (D-Warren), would create a license for kratom sales and manufacturing, require testing of products and require new safety warnings on kratom substances sold in Michigan. While the MHA prefers a federal Schedule I ban of the drug, the association is supportive of HB 5477, which will help limit adolescent addiction and prevent adulterated products from being on the market.

Members with questions on these bills or any other state legislation should contact Adam Carlson at the MHA.

MHA Monday Report Aug. 29, 2022

MHA Monday Report

Behavioral Health Legislation Introduced in State House

capitol building

New legislation to make changes to the screening process for potential admission to inpatient psychiatric care for behavioral and mental health patients was introduced Aug. 17 in the Michigan House of Representatives. Rep. Graham Filler …


Court of Appeals Rules for Providers in ANF Case


CMS Releases FY 2023 Final Rule to Update Skilled Nursing Facilities PPS


CMS Wage Data Revisions Due Sept. 2


Member Feedback Requested on Proposed Telemedicine Policy


Paul KeckleyThe Keckley Report

Game On: FTC Takes on Hospital Consolidation via COPA Dismantling

“The Federal Trade Commission (FTC) issued a scathing 20-page report last Monday criticizing hospital Certificate of Public Advantage (COPA) agreements and urging state lawmakers to suspend their use. …

The FTC has its sights on hospital consolidation: it’s high on the list of industries where its activist’ muscle is likely to be flexed more frequently and effectively. … Like strong bipartisan support for the Hospital Price Transparency Rule, it reflects the FTC’s rejection of hospital claims about inadequate reimbursement by payers including Medicare and Medicaid, price gauging by device, drug and technology suppliers and unfair competition from insurers and niche providers often funded by private investment to optimize profits at the expense of hospitals.

And it offers a solution that’s strong on populist appeal but weak on practical implementation in the current hospital environment: competition vs. consolidation. Regulatory Constraints on hospitals like EMTALA and others are not applied to insurers and retailers who offer a widening range of care management services in direct competition with hospitals. The playing field is increasingly tilted against hospitals.

Paul Keckley, August 22, 2022


News to Know


MHA in the News

MHA CEO Brian Peters

Member Feedback Requested on Proposed Telemedicine Policy

The Michigan Department of Health and Human Services (MDHHS) recently released a proposed policy to update Medicaid coverage of telemedicine services after the conclusion of the federal COVID-19 public health emergency (PHE). The policy outlines several updates, including:

  • Making permanent policies established during the PHE through bulletins MSA 20-09 (General Telemedicine Policy Changes) and MSA 21-24 (Asynchronous telemedicine services). MSA 20-09 requires either direct or indirect patient consent for all telemedicine services and defines originating and distant sites. MSA 21-24 clarifies Medicaid coverage for asynchronous telemedicine services, including store and forward services, remote patient monitoring and interprofessional consultations.
  • Not requiring prior authorization unless the equivalent in-person service requires prior authorization. Authorization requirements for Medicaid health plans may vary.
  • Establishing payment rates for allowable telemedicine services at the same level as in-person services. To effectuate this policy, the provider must report the place of service as they would if they were providing the service in-person, along with modifier 95 – Synchronous Telemedicine Service. *MDHHS varies from Medicare telehealth billing by not using place of service 02 or 10 but aligns in the use of modifier 95.
  • Allowing audio-only telemedicine services only for select situations where the beneficiary does not have access to audio/visual capabilities. These codes are currently represented as CPT codes 99441-99443 and 98966-98968.

Members are encouraged to submit comments to the MDHHS by Sept. 20. Questions should be directed to Renée Smiddy at the MHA.

State Budget Advances to Governor’s Desk

capitol building

capitol buildingThe fiscal year (FY) 2023 state budget bills were approved by the Michigan Legislature July 1. House Bill (HB) 5783 and Senate Bill (SB) 845, which provide for the FY 2023 budget, now go to the governor’s desk for final review and signature into law.

In a statement released July 1, MHA CEO Brian Peters said, “The fiscal year 2023 state budget approved by the Michigan Legislature provides necessary resources to assist hospitals and health systems in advancing the health of individuals and communities throughout our state. We appreciate the work and consideration placed by lawmakers that continues to protect hospital priorities.”

These priorities include maintaining funding for the Healthy Michigan Plan, graduate medical education of physician residents, disproportionate share hospitals that treat the highest numbers of uninsured and underinsured patients, the rural access pool and obstetrical stabilization fund, and critical access hospital reimbursement rates, all of which support access to healthcare services in rural areas. Each of these areas are instrumental in keeping hospitals financially secure, particularly in areas serving vulnerable and underserved populations.

The budget also supports MHA and hospital priorities with new funding to improve and enhance state behavioral health facility capacity and address the healthcare workforce. Michigan lacks adequate capacity to treat patients with behavioral and mental illness, and this new funding is an important and necessary step to address the shortage. The investment of state funds to expand access to Bachelor of Science in nursing degree programs at the state’s community colleges is a significant movement toward replenishing Michigan’s healthcare talent pipeline.

In other action, the House of Representatives supported legislation to create an opt-out grant program for hospitals to establish medication-assisted treatment (MAT) for substance use disorders in their emergency departments. SB 579, introduced by Sen. Curt VanderWall (R-Ludington), now returns to the Senate for a final concurrence vote before it is sent for the governor’s signature. Hospitals provided MAT programs prior to introduction of the bill, and the MHA has already partnered with the Michigan Department of Health and Human Services (MDHHS) to implement the first round of grants provided under this legislation. No hospitals would be required to participate in the program.

The full Senate advanced to the House of Representatives a bill to register certain medical laboratories in Michigan. SB 812, also introduced by VanderWall, would create a registry for interventional pain management, kidney access and vascular laboratories. As currently written, SB 812 would not provide any form of oversight or clinical requirements for the registered labs, and the MDHHS would not have authority to deny or remove registered labs from the list. The MHA has not taken a position on the bill but is closely monitoring any changes.

Finally, a bill related to telemedicine was introduced in the Senate. SB 1135, introduced by Sen. Mike MacDonald (R-Macomb Township), would amend the state’s Social Welfare Act to ensure that recent expansions in telehealth visit coverage also apply to the Medicaid Medical Assistance Program and Healthy Michigan Program. The bill would specify that recipients are covered equally for telehealth visits, expand the “distant site” definition, and ensure that providers are reimbursed at an equal rate to in-person services. The MHA is reviewing the legislation and has not yet taken a position on the bill. The association will keep members apprised of future action.

Members with questions on state legislation related to healthcare should contact Adam Carlson at the MHA.